Atherosclerosis and cardiovascular risk reduction with PPAR agonists.

Curr Atheroscler Rep

Department of Medicine, University of Kuopio and Kuopio University Hospital, POB 1777, FIN-70211 Kuopio, Finland.

Published: October 2007

Peroxisome proliferator-activated receptors (PPARs) are transcriptional factors belonging to the nuclear receptor superfamily. Three isoforms, PPARalpha, PPARgamma, and PPARdelta, which are encoded by separate genes, have been identified. The PPARs act as gene regulators of various metabolic pathways in energy and lipid metabolism, glucose homeostasis, adipogenesis, and inflammation. Two key classes of synthetic compounds, fibrates and thiazolidinediones (glitazones), activate PPARalpha and PPARgamma, respectively. Both of these drugs have several properties that prevent atherosclerosis in the vascular wall and reduce the levels of risk factors for cardiovascular disease. However, clinical trials have not produced convincing evidence that cardiovascular disease is prevented with the use of PPARalpha and PPARgamma agonists.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11883-007-0033-4DOI Listing

Publication Analysis

Top Keywords

pparalpha ppargamma
12
cardiovascular disease
8
atherosclerosis cardiovascular
4
cardiovascular risk
4
risk reduction
4
reduction ppar
4
ppar agonists
4
agonists peroxisome
4
peroxisome proliferator-activated
4
proliferator-activated receptors
4

Similar Publications

α-amanitin induces hepatotoxicity via PPAR-γ inhibition and NLRP3 inflammasome activation.

Ecotoxicol Environ Saf

January 2025

Department of Forensic Medicine, School of Forensic Medicine, Kunming Medical University, Kunming, China. Electronic address:

Mushroom poisoning, predominantly caused by α-amanitin, is a critical food safety concern in worldwide, with severe cases leading to hepatotoxicity and fatalities. This study delves into the hepatotoxic effects of α-amanitin, focusing on the NLRP3 inflammasome and PPAR-γ's regulatory role in inflammation. In vitro studies with L-02 cells showed that α-amanitin reduces cell viability and triggers NLRP3 inflammasome activation, increasing NF-κB phosphorylation and pro-inflammatory cytokines IL-18 and IL-1β.

View Article and Find Full Text PDF

L. is known in Europe for its cardioactivity-also in interrelation with known risk factors of the metabolic syndrome-just as Houtt. in East Asia; however, up to now, no active constituents could be identified.

View Article and Find Full Text PDF

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease without an approved pharmacological approach for its prevention/treatment. Based on the modified Delphi process, NAFLD was redefined as metabolic dysfunction-associated steatotic liver disease (MASLD) to highlight the metabolic aspect of liver pathogenesis. Chios mastiha ( var.

View Article and Find Full Text PDF

In May 2021, the M/V ship fire disaster led to the largest maritime spill of resin pellets (nurdles) and burnt plastic (pyroplastic). Field samples collected from beaches in Sri Lanka nearest to the ship comprised nurdles and pieces of pyroplastic. Three years later, the toxicity of the spilled material remains unresolved.

View Article and Find Full Text PDF

High-throughput screening of protein interactions with per- and polyfluoroalkyl substances (PFAS) used in photolithography.

J Hazard Mater

January 2025

Department of Civil & Environmental Engineering, University of Pittsburgh, 3700 O'Hara St., Pittsburgh, PA 15261, USA; Department of Environmental and Occupational Health, University of Pittsburgh, 3700 O'Hara St., Pittsburgh, PA 15261, USA. Electronic address:

Per- and polyfluoroalkyl substances (PFAS) are synthetic chemicals used extensively across industries, including semiconductor manufacturing. Semiconductors are ubiquitous, and there is increasing global demand for semiconductors, e.g.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!